Top Markets
Coin of the day
Bioqual, Inc. Bioqual, Inc.

Bioqual, Inc.

BIOQ
Rangering i aksjer #28023
Bioqual, Inc. delivers a range of preclinical research solutions, encompassing... Bioqual, Inc. delivers a range of preclinical research solutions, encompassing both in-vivo and in-vitro methodologies, to its diverse clientele of commercial enterprises and government agencies across the United States. Their expertise spans numerous critical health domains, including investigations into COVID-19, AIDS, influenza, RSV infection, and various flaviviruses such as Zika and Dengue. Furthermore, their work extends to malaria, hepatitis, and oncology. The firm's comprehensive laboratory capabilities further include processing biological samples, producing virus stocks, precisely quantifying infectious viral loads, and conducting assays like virus neutralization and hemagglutination inhibition. They also utilize advanced techniques such as quantitative PCR, ELISA for antigen and antibody detection, flow cytometry, lymphocyte proliferation studies, and various other cell-based analytical methods. Moreover, Bioqual furnishes specialized support for studies employing animal research models. Established in 1981, Bioqual, Inc. maintains its primary operational base in Rockville, Maryland.
Aksjekurs
$32.50
Sist synkronisert: 2026-08-18
Markedsverdi
$29.07M
Endring (1 dag)
0.00%
Endring (1 år)
-24.75%
Land
US
Handel Bioqual, Inc. (BIOQ)

Kategori

P/S-forhold for Bioqual, Inc. (BIOQ)
P/S-forhold per 2026 TTM: 0
Ifølge Bioqual, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Bioqual, Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
4.72 -
US
5.67 -
US
- -
CN
16.40 -
US
9.55 -
US